shareholder update

LONDON: Belluscura plc (AIM: BELL), a UK-based medical device innovator specializing in portable oxygen enrichment technology, has launched a strategic funding initiative to strengthen its capital base and support growth. As part of the plan, the company’s wholly owned U.S. subsidiary, Belluscura LLC, has signed a secured convertible loan note agreement to raise up to…